The attack's financial impact was confined to the first quarter. Stryker has not disclosed the full dollar amount of losses but confirmed no material effect on full-year guidance. The company faces at least six employee lawsuits over stolen personal data resulting from the breach. Details regarding the scope of compromised information and settlement discussions remain undisclosed.
Attorneys should monitor two developments. First, the litigation over data theft may establish precedent for liability standards when geopolitically motivated attacks target healthcare infrastructure. Second, Stryker's quick recovery and limited full-year impact may obscure deeper supply chain vulnerabilities—the company reaffirmed 2026 guidance of 8 to 9.5 percent organic sales growth and adjusted earnings per share of $14.90 to $15.10, but investors sold shares 2 percent lower in after-hours trading, signaling concern about future cyber resilience in the sector.